Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1619 1672
This examiner grants 33% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18072449 | ANTIGEN-PRESENTING CELL-MIMETIC SCAFFOLDS AND METHODS FOR MAKING AND USING THE SAME | Non-Final OA | President and Fellows of Harvard College |
| 17611272 | METHODS AND COMPOSITIONS FOR TREATING CARDIOMYOCYTES | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18036207 | DELAYED RELEASE SOFTGEL CAPSULES | Final Rejection | R.P. Scherer Technologies, LLC |
| 18199625 | OZONE-BASED LOW TEMPERATURE SILICON OXIDE COATING FOR PHARMACEUTICAL APPLICATIONS | Final Rejection | Applied Materials, Inc. |
| 18020246 | Multicomponent Delivery Systems for Polyanionic Cargo Compound Delivery | Final Rejection | NUTCRACKER THERAPEUTICS, INC. |
| 18391998 | POLYMERIC IMPLANTS WITH HIGH DRUG LOADING AND LONG-ACTING DRUG RELEASE AND METHODS OF MAKING THE SAME | Non-Final OA | The University of North Carolina at Chapel Hill |
| 17430837 | Extracellular Vesicle Functionalization Using Oligonucleotide Tethers | Final Rejection | Carnegie Mellon University |
| 16935963 | IN VIVO CROSSLINKING OF EMBOLIC HYDROGELS USING BIOORTHOGONAL CLICK CHEMISTRY | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18576185 | PASTE-LIKE SILICONE COMPOSITION, METHOD FOR PRODUCING THE SAME, AND COSMETICS | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 17421618 | Titanium Dioxide Coatings for Medical Devices Made by Atomic Layer Deposition | Non-Final OA | Northeastern University |
| 18585517 | Dry Shampoo Spray Foam Technology | Non-Final OA | Henkel AG & Co. KGaA |
| 17765625 | LIPOSOMAL CANNABINOIDS AND USES THEREOF | Final Rejection | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD |
| 17973481 | SYSTEM AND METHOD OF ISOLATION, SELECTION, AND USE OF INDIGENOUS MICROBES FOR CARBON CAPTURE AND INCREASING THE WATER HOLDING CAPACITY IN AGRICULTURAL SOILS | Final Rejection | MYLAND COMPANY, INC. |
| 18269119 | HAIR CARE COMPOSITION | Final Rejection | Conopco, Inc., d/b/a UNILEVER |
| 18036268 | WASH COMPOSITION | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18585269 | METHOD AND SYSTEM FOR ASSOCIATING SECONDARY MATERIALS WITH A TISSUE GRAFT AND MODIFIED TISSUE GRAFTS | Non-Final OA | CellTherX Corp |
| 17760390 | COMPOSITIONS AND APPLICATIONS THEREOF | Non-Final OA | Kenvue Brands LLC |
| 18450086 | TRIPLE STABILIZER SYSTEM | Non-Final OA | Bayer Aktiengesellschaft |
| 18250570 | CRYSTAL-FREE HIGH-CONCENTRATION TESTOSTERONE CYPIONATE FORMULATIONS | Final Rejection | Pfizer Inc. |
| 18691620 | COSMETIC COMPOSITION | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 18278304 | TRANSDERMAL PATCH FOR TREATING OSTEOARTHRITIS | Non-Final OA | HISAMITSU PHARMACEUTICAL CO., INC. |
| 17534956 | Stable Liquid Lipid Nanoparticle Formulations | Final Rejection | Translate Bio, Inc. |
| 17611020 | IMPROVED PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | Non-Final OA | Translate Bio, Inc. |
| 18293058 | COMPOSITIONS AND METHODS | Non-Final OA | Glasport Bio Limited |
| 17925957 | HYDROGEL PRODUCING DEVICE FOR SAMPLING OF THE INTESTINAL LUMEN | Final Rejection | Danmarks Tekniske Universitet |
| 18543539 | ORAL FELINE FEED AND METHODS FOR CONTROLLING FLEA INFESTATIONS IN A FELINE | Non-Final OA | In the Bowl Animal Health, Inc. |
| 18544271 | SPRAYABLE COMPOSITIONS CONTAINING OIL-IN-WATER DISPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF, AND METHODS OF USE THEREOF | Non-Final OA | Leading Edge Innovations, LLC |
| 18526027 | Method and Product for the Identification of Diseased Animals | Non-Final OA | Sideris Pet Pharmaceuticals, LP |
| 18563311 | APPLICATION OF PHARMACEUTICAL COMPOSITION HAVING SPECIFIC DRUG-TO-LIPID RATIO IN ANTITUMOR | Non-Final OA | Highfield Biopharmaceuticals Corporation |
| 18507629 | BOTANICAL BASED BIO-STIMULANT, BIO-ACARICIDAL COMPOSITIONS | Non-Final OA | KAY BEE BIO ORGANICS PVT LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy